Du är här


Aqua Bio Technology: Best first half year result ever for Aqua Bio Technology

ua Bio Technology ASA (Oslo Axess: ABT) today announced the second quarter
2015 financial results. Revenues were in line with previously announced
contracts and saw a strong growth from the second quarter last year. Also
the Company's profitability improved significantly. The combined results in
the two first quarters of 2015 make the first half of 2015 ABT's best first
half year ever.

Aqua Bio Technology had revenues of NOK 9.0 million in the second quarter, up
from NOK 5.2 million in the corresponding quarter last year. EBITDA for the
quarter ended at NOK 4.7 million, representing an EBITDA margin of 52.2 per
cent. Last year's EBITDA of NOK -0.2 million was adversely affected by a
legal dispute in the United States. ABTs net result for the second quarter
2015 was NOK 3.2 million, compared to NOK -1.7 million last year.

For the first half of 2015 ABT had revenues of NOK 18.1 million, up from NOK
10.6 million in the first six months of last year. EBITDA for the first half
was NOK 10.0 million, compared to NOK 1.0 million last year. The first half's
net result ended at NOK 7.3 million, against NOK -2.1 million last year.

"We enjoy a strong financial position and have a transparent revenue stream
the next couple of years. On this basis we are now looking to expand our
business through establishing partnerships with other bio technology
companies, and leverage from our sales and marketing expertise," said Aqua
Bio Technology's CEO Arvid Lindberg.

For further information, please call Arvid Lindberg, CEO, telephone +47 9824

Aqua Bio Technology (ABT) has launched several cosmetic ingredients to the
global skincare market. The ingredient, based on the Company's unique, marine
technology and other technologies, have documented positive effects on the
skin. Skin care is the fastest growing segment in the cosmetics industry,
where ABT's ingredients have established a foothold. In addition to
ingredients from its own technology, ABT also commercializes
technologies/ingredients for partners, for use in novel skin care products.
Aqua Bio Technology i listed on the Axess market of the Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

ABT Q2 2015 presentation
ABT Q2 2015 press release
ABT Q2 2015 report in Norwegian


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aqua Bio Technology via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.